Menu
Recruiting NCT04010188

A Registered Cohort Study on Charcot-Marie-Tooth Disease

Observational Charcot-Marie-Tooth Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Charcot-Marie-Tooth Disease. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Registered Observational Cohort Study of Charcot-Marie-Tooth Disease

Overview

The aim of the study is to analyze the natural history data data from Charcot-Marie-Tooth disease and related disorders in China, to assess the clinical, genetic, epigenetic features of patients with Charcot-Marie-Tooth disease, and to optimize clinical management.

Primary outcome measures

  • The change of Charcot-Marie-Tooth Neuropathy Score (CMTNS) during 6 month [Time frame: Up to 6 months]

Eligibility criteria

Inclusion criteria

  • Patients with the clinical diagnosis of Charcot-Marie-Tooth disease
  • Genetic diagnosis of patients with Charcot-Marie-Tooth disease
  • Unrelated healthy controls

Exclusion criteria

  • Decline to participate.
  • Other peripheral neuropathy caused by trauma, immunity and toxicosis.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • First Affiliated Hospital of Fujian Medical University — Fuzhou

Identifiers

NCT: NCT04010188 · MRCTA,ECFAH of FMU [2019] 192

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗